Domestically-made innovative drugs usher in a "golden" development period, and the demand for high-end pharmaceutical machines is expected to increase significantly

[ Focus on Chemical Machinery and Equipment Network ] In recent years, under the influence of domestic review and R&D efficiency improvement, dynamic adjustment of medical insurance catalogue, policy vigorously guide innovation, continuous capital influx and other factors, the research and development of domestic innovative drugs has been accelerating, and innovative drugs Results have also continued to emerge
.

It is understood that a number of new domestic drugs have been approved for the market recently
.
For example, on June 9th, the National Food and Drug Administration (NMPA) announced that it would approve the listing of Rongchang Bioinjection Vedicuzumab (trade name: Aidixi) with conditions through the priority review and approval procedure, which marks the ushering of China Introduced the first antibody-conjugated drug (ADC)
.
On the same day, NMPA through priority review approval process, approved the Suzhou Ze Jing Bio-Pharmaceutical Corp.
declared a Class 1 drug innovation toluene sulfonic acid Dona sorafenib tablets (trade name: Zep students) on the market
.
The drug is also an innovative drug independently researched and developed by China with independent intellectual property rights
.

 

In addition to the above innovative drugs, since 2021, according to public information, at least 5 innovative drugs developed by Chinese companies have also submitted applications for marketing in the United States
.

 

On the whole, the ecological environment of China's new drug research and development can be said to be maturing day by day.
China's new drug research and development has started and it is beginning to usher in the golden age of development
.
It is worth noting that with the continuous development of China's innovative drug industry, in the face of the new situation, the industry generally believes that equipment innovation and product line upgrades are also imperative
.
Since drug R&D, production and pharmaceutical equipment are inseparable, in the process of accelerating pharmaceutical innovation, pharmaceutical companies' demand for pharmaceutical equipment, especially high-end pharmaceutical equipment , will continue to expand
.

 

If workers want to do well, they must first sharpen their tools.
As the requirements and needs of pharmaceutical companies change, pharmaceutical equipment not only needs to meet policy standards, but it will also increasingly need to be high-end
.
It is understood that many pharmaceutical companies have begun to pursue more intelligent pharmaceutical equipment that can improve production efficiency to ensure that safer and more effective high-quality drugs can be stably produced
.
If there are pharmaceutical machinery companies, they attach great importance to software and hardware facilities, and independently research and develop an informatized, intelligent, and lightweight security system for the clean area of ​​the pharmaceutical workshop.
The system has a powerful digital processing function and a full network transmission function in the backstage.
The cleaning, sterilization, and life management of consumables such as clothing achieves intelligent data management, which not only meets the needs of GMP production management, but also successfully integrates into the intelligent era of industrial information 4.
0
.

 

Judging from the current innovation and development trend of the pharmaceutical industry, pharmaceutical companies will have higher and higher requirements for high-end pharmaceutical equipment
.
It is understood that the high-end requirements of pharmaceutical equipment include many factors, such as basic quality requirements, energy conservation and environmental protection in line with policies and industry trends, intelligence, and innovative technologies that have been mentioned
.
In recent years, in fact, pharmaceutical equipment industry has begun through continuous efforts to develop a large number of new high-end equipment, technology, and new solutions: new formulations such as process equipment, efficient protein separation and purification equipment, large-scale bio- reactor and ancillary system, flexible production line preparation of sterile, solid preparation continuous production equipment, advanced powder engineering equipment
.

 

Among them, it is worth mentioning that with the continuous advancement of science and technology, more and more companies have begun to leverage intelligence and digitalization to actively research and develop high-end pharmaceutical equipment and technologies
.
If any company uses the digital chromatography system, shorten the manufacturing cycle of pharmaceutical equipment hardware, create, store, and call mature formula technology, ensure the stability and reproducibility of pharmaceutical technology, and make the design and manufacturing of pharmaceutical equipment more standardized and modular
.

 

It is worth noting that the National Development and Reform Commission and other four departments jointly issued the "Guiding Opinions on Expanding Investment in Strategic Emerging Industries, Cultivating and Growing New Growth Pole Growth Pole", which clearly stated that it is necessary to focus on supporting the production of high-end equipment such as high-end medical equipment and pharmaceutical equipment.
, Implement pilot demonstrations of smart manufacturing and smart construction
.
Affected by this, the industry predicts that in the future, more and more pharmaceutical equipment companies with independent research and development capabilities will continue to improve and innovate in technology, develop towards the mid-to-high-end direction, create more intelligent and modern pharmaceutical equipment, and help pharmaceutical companies improve The level of production automation improves efficiency and reduces costs
.
In this context, China's high-end pharmaceutical equipment may have more and more achievements, and domestic substitution may also be expected to usher in a major breakthrough
.

 

　　Original title: Domestically produced innovative drugs usher in a "golden" development period, and demand for high-end pharmaceutical machines is expected to increase significantly